Get the Stockscreener App
220.15
0.42%
-0.92
After Hours:
209.15
-11.00
-5.00%
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MSN
West Pharmaceutical Services: How GLP-1 and Biologics Are Unlocking Explosive Growth! - Smartkarma
Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
West Pharmaceutical sets Q2 dividend at $0.21 per share By Investing.com - Investing.com Australia
Insider Decision Unfolding At West Pharmaceutical Servs: Eric Green Exercises Options, Resulting In $0 - Benzinga
Chad Winters Decides To Exercise Options At West Pharmaceutical Servs Worth $0 - Benzinga
Options Exercise Update At West Pharmaceutical Servs: Kimberly MacKay Engages, Resulting In $0 - Benzinga
Engaging In Insider Activity, Cindy Reiss-Clark At West Pharmaceutical Servs Exercises Options Worth $0 - Benzinga
West Pharmaceutical Services, Inc. Announces Second Quarter 2025 Dividend, Payable on May 7, 2025 - Marketscreener.com
West Announces Second-Quarter Dividend - The Malaysian Reserve
West Pharmaceutical sets Q2 dividend at $0.21 per share - Investing.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $240 From $393, Maintains Buy Rating - Marketscreener.com
West Pharmaceutical Services Reports Strong Q4, Introduces 2025 Financial Guidance - MSN
WEST PHARMACEUTICAL SERVICES INC SEC 10-K Report - TradingView
Wall Street Bounces Back: Top-Performing ETFs Of Last Week - Benzinga
Why Did West Pharmaceutical Services Stock Drop Almost 40%? - Nasdaq
Why West Pharmaceutical Services (WST) Crashed Last Week? - MSN
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down - MSN
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities (NYSE:WST) - Seeking Alpha
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? - Benzinga
West Pharmaceutical Services, Inc. (NYSE:WST) Just Reported, And Analysts Assigned A US$306 Price Target - Yahoo Finance UK
West Pharma upgraded at Deutsche Bank despite earnings led selloff - MSN
West Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue - Medical Dialogues
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stock Position Raised by Van ECK Associates Corp - MarketBeat
Consolidated Planning Corp Buys 2,051 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma stock falls as 2025 guidance disappoints - MSN
KeyCorp Has Lowered Expectations for West Pharmaceutical Services (NYSE:WST) Stock Price - MarketBeat
West Pharmaceutical Services (NYSE:WST) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
West Pharmaceutical Services, Inc.'s (NYSE:WST) Popularity With Investors Under Threat As Stock Sinks 35% - Simply Wall St
West Pharmaceutical Services (NYSE:WST) Rating Increased to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to Buy - MarketBeat
West Pharma’s Stock Plummets 38% as 2025 Outlook Disappoints Investors - PUNE.NEWS
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
Dynavax Technologies Corporation Enters into an Agreement with West Pharmaceutical Services, Inc - Marketscreener.com
Sector Update: Health Care Stocks Decline Late Afternoon -February 14, 2025 at 03:59 pm EST - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Sector Update: Health Care Stocks Retreat Friday Afternoon -February 14, 2025 at 01:59 pm EST - Marketscreener.com
Why West Pharmaceutical Shares Are on the Rise Again - TipRanks
West Earnings: Valuation Lowered After Guidance Disappoints and Recovery Trajectory Delayed - Morningstar
West Pharmaceutical Servs's Options Frenzy: What You Need to Know - Benzinga
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Stock Market Surge: Tesla, Nvidia, and Other Mega-Cap Movers Drive Market Dynamics While West Pharma and Trade Desk Struggle – market - HPBL
Citigroup Adjusts Price Target on West Pharmaceutical Services to $300 From $400 - Marketscreener.com
KeyBanc Adjusts Price Target on West Pharmaceutical Services to $325 From $470 - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Reaches New 52-Week LowWhat's Next? - MarketBeat
West Pharmaceutical Services Stock Touches 'Attractive Entry Point,' Deutsche Bank Says - Marketscreener.com
West Pharma stock upgraded at Deutsche Bank (WST:NYSE) - Seeking Alpha
West Pharmaceutical forecasts 2025 results below expectations, shares drop - MSN
West Pharmaceutical Services (NYSE:WST) Updates FY 2025 Earnings Guidance - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript - Insider Monkey
West Pharmaceutical price target lowered to $325 from $470 at KeyBanc - TipRanks
Sumitomo Mitsui Trust Group Inc. Has $58.75 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma (WST) Stock Leads S&P 500 Rout with 38% Slump - TipRanks
0.34%
2.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):